Back

Spatial atlas highlights contribution of C. difficile in early-stage colorectal cancer

Markham, N.;Drewes, J.;Green, E.;Ball, W.;Lunnemann, H.;Simmons, A.;Kaur, H.;Queen, J.;Geis, A.;Pourmaleki, M.;Helm, B.;Storrs, E.;Ramirez-Solano, M.;Li, X.;Ma, Z.;Revetta, F.;Windon, A.;Washington, M.;Wanyiri, J.;Roslani, A.;Iyadorai, T.;Vadivelu, J.;Coggin, J.;Meenderink, L.;Lacy, D.;Curtis, C.;Ma, S.;Ding, L.;Liu, Q.;Shrubsole, M.;Lau, K.;Sears, C.;Jr., R.

2026-06-20 Cancer Biology
10.64898/2026.06.18.733268 bioRxiv
Show abstract

Background and AimsIntratumoral heterogeneity with respect to both host and microbial components has emerged as an important contributor to colorectal cancer (CRC) biology. Although the overall taxonomy and abundance of the CRC tumor microbiome have become well characterized, much less is known about bacterial niches within the tumor microenvironment (TME). Escherichia coli and Fusobacterium nucleatum are highly prevalent and abundant species linked to CRC. Less abundant organisms, like Clostridioides difficile and Enterocloster aldenensis, are emerging as potentially important CRC-associated bacteria. Additionally, many studies are confounded by preoperative oral antibiotics or the inclusion of late-stage cancers, both of which may alter the gut microbiome. To better understand the spatial relationships between bacteria and CRC, we generated a molecular atlas based on surgically resected tissue specimens collected from a unique cohort of early-stage CRC patients in whom oral antibiotics were not administered preoperatively. MethodsFrom 20 CRC specimens, we performed matched histopathological analysis, fluorescence in situ hybridization (FISH), whole exome sequencing (WES), 16S rRNA amplicon bacterial DNA sequencing, codetection by indexing (CODEX) multiplex immunofluorescence, and spatial transcriptomics of 756 regions among the specimens. We used 16S rRNA amplicon sequencing data to design and experimentally validate custom bacterial probes that were applied to the spatial transcriptomics. Human colonic organoids were used to validate the relationship between Clostridioides difficile toxin B (TcdB) and an E-twenty-six family transcription factor, ELF3. ResultsWe identified eight intratumoral bacterial niches consisting of a variety of bacterial species, and each niche was associated with unique tumor features. We further defined tumor gene expression patterns correlating with individual bacterial species and show that C. difficile has a disproportionate impact on the tumor transcriptome given its relatively low abundance. Specifically, TcdB induces nuclear localization of ELF3, increased cytosolic {beta}-catenin protein, and upregulated WNT signaling. ConclusionOur study integrates multi-omics to identify bacterial species with biological and spatial relevance in CRC regardless of abundance. These findings will enable further studies to define diagnostic and therapeutic targets for bacteria-associated CRC.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Gut Microbes
78 papers in training set
Top 0.1%
31.7%
2
Genome Medicine
183 papers in training set
Top 0.2%
9.1%
3
Scientific Reports
3612 papers in training set
Top 10%
6.9%
4
npj Biofilms and Microbiomes
58 papers in training set
Top 0.1%
6.4%
50% of probability mass above
5
mSystems
394 papers in training set
Top 2%
3.5%
6
Communications Medicine
113 papers in training set
Top 1%
2.5%
7
Frontiers in Microbiology
427 papers in training set
Top 4%
2.5%
8
BMC Cancer
67 papers in training set
Top 0.8%
2.4%
9
Nature Communications
5641 papers in training set
Top 41%
2.2%
10
PLOS ONE
5266 papers in training set
Top 47%
1.8%
11
Cancers
213 papers in training set
Top 4%
1.2%
12
Microbiology Spectrum
469 papers in training set
Top 8%
1.2%
13
mSphere
302 papers in training set
Top 5%
1.2%
14
Microbiome
154 papers in training set
Top 2%
1.1%
15
JCI Insight
277 papers in training set
Top 6%
1.1%
16
Frontiers in Immunology
638 papers in training set
Top 8%
1.1%
17
Cell Reports Medicine
153 papers in training set
Top 4%
1.0%
18
mBio
833 papers in training set
Top 10%
0.9%
19
eLife
5828 papers in training set
Top 62%
0.9%
20
International Journal of Cancer
49 papers in training set
Top 1%
0.9%
21
iScience
1154 papers in training set
Top 38%
0.6%
22
BMC Microbiology
49 papers in training set
Top 2%
0.6%
23
OncoImmunology
24 papers in training set
Top 0.7%
0.6%
24
Cellular and Molecular Gastroenterology and Hepatology
46 papers in training set
Top 1%
0.6%
25
Gastroenterology
42 papers in training set
Top 1%
0.6%